CA Stock MarketDetailed Quotes
TTI Thiogenesis Therapeutics Corp
- 0.650
- +0.010+1.56%
15min DelayMarket Closed Jul 12 16:00 ET
29.57MMarket Cap-5416P/E (TTM)
0.660High0.640Low145.50KVolume0.660Open0.640Pre Close94.51KTurnover1.06052wk High0.41%Turnover Ratio45.50MShares0.60052wk Low-0.12EPS TTM22.96MFloat Cap1.060Historical HighLossP/E (Static)35.32MShs Float0.375Historical Low-0.13EPS LYR3.13%Amplitude--Dividend TTM5.56P/B1Lot Size--Div YieldTTM
Thiogenesis Therapeutics Corp Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -128.10%-2M | -55.45%-3.25M | -146.45%-696.61K | -66.93%-991.64K | 41.98%-685.15K | -2,618.35%-875.06K | -5,724.44%-2.09M | -282.66K | -594.05K | -1.18M |
| Net income from continuing operations | 33.38%-710.57K | -29.02%-5.06M | -365.12%-2.07M | -49.42%-1.05M | -75.08%-870.39K | 53.13%-1.07M | -4,134.29%-3.92M | ---445.34K | ---705.78K | ---497.14K |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---56.19K | ---125.67K | --0 | --0 |
| Remuneration paid in stock | -53.90%80.37K | -8.29%480.91K | -59.97%94.53K | -9.69%90.64K | 26.19%121.39K | 90.18%174.36K | --524.37K | --236.12K | --100.37K | --96.19K |
| Other non cashItems | ---- | ---- | ---- | ---- | ---- | ---- | --1.94M | --77.77K | ---1 | --1 |
| Change In working capital | -8,013.00%-1.37M | 334.46%1.33M | 5,114.12%1.28M | -343.98%-27.73K | 108.19%63.85K | -92.34%17.26K | -1,101.42%-568.81K | ---25.53K | --11.37K | ---779.85K |
| -Change in receivables | -127.84%-10.31K | -126.07%-29.33K | -25.26%-40.02K | 4,417.07%1.85K | -51.76%-28.18K | -77.28%37.03K | --112.48K | ---31.95K | --41 | ---18.57K |
| -Change in prepaid assets | -56.48%12.79K | -10.69%-42.75K | -86.80%-72.15K | ---191 | --200 | --29.39K | ---38.62K | ---38.62K | --0 | --0 |
| -Change in payables and accrued expense | -2,683.69%-1.37M | 318.73%1.41M | 2,991.39%1.39M | -359.53%-29.39K | 112.06%91.84K | -178.96%-49.15K | -1,231.45%-642.66K | --45.04K | --11.33K | ---761.28K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -128.10%-2M | -55.45%-3.25M | -146.45%-696.61K | -66.93%-991.64K | 41.98%-685.15K | -2,618.35%-875.06K | -5,724.44%-2.09M | ---282.66K | ---594.05K | ---1.18M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | 107.46K | -3.24M | 0 | 0 | |||
| Net business purchase and sale | ---- | --0 | --0 | --0 | ---- | ---- | --107.46K | ---3.24M | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | --0 | --0 | --0 | ---- | ---- | --107.46K | ---3.24M | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 462.5K | -49.29%4.12M | -49.80%4.12M | 0 | 0 | 0 | 7,387,746.36%8.13M | 8.21M | 3.68K | |
| Net issuance payments of debt | ---- | --0 | --0 | --0 | ---- | ---- | ---175.17K | --25K | --0 | ---- |
| Net common stock issuance | ---- | -15.55%4.12M | ---- | ---- | ---- | ---- | --4.88M | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | --462.5K | --0 | --0 | --0 | --0 | --0 | 3,110,657.27%3.42M | --3.31M | --3.68K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --462.5K | -49.29%4.12M | -49.80%4.12M | --0 | --0 | --0 | 7,387,746.36%8.13M | --8.21M | --3.68K | ---- |
| Net cash flow | ||||||||||
| Beginning cash position | 14.21%7.08M | 9,805.77%6.2M | 125.03%3.63M | 109.57%4.64M | 51.86%5.32M | 9,951.69%6.2M | -65.67%62.55K | --1.61M | --2.22M | --3.5M |
| Current changes in cash | -75.24%-1.53M | -85.80%872.76K | -26.90%3.42M | -67.97%-991.64K | 45.98%-685.15K | -126.37%-875.06K | 17,278.47%6.14M | --4.68M | ---590.37K | ---1.27M |
| Effect of exchange rate changes | -718.32%-19.03K | 169.05%7.58K | 119.38%20.08K | -74.59%-19.29K | 148.38%9.12K | -101.90%-2.33K | ---10.98K | ---103.58K | ---11.05K | ---18.85K |
| End cash Position | 3.86%5.52M | 14.21%7.08M | 14.21%7.08M | 125.03%3.63M | 109.57%4.64M | 51.86%5.32M | 4,131.32%6.2M | --6.2M | --1.61M | --2.22M |
| Free cash from | -128.10%-2M | -55.45%-3.25M | -146.45%-696.61K | -66.93%-991.64K | 41.98%-685.15K | -2,618.35%-875.06K | -5,724.44%-2.09M | ---282.66K | ---594.05K | ---1.18M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg